ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy

Go back to ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.66 +0.64 (1.28%)
Previous Close $50.02    52 Week High $45.58 
Open $50.29    52 Week Low $37.82 
Day High $50.70    P/E N/A 
Day Low $49.97    EPS $0.00 
Volume 422,755       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.66 +0.64 (1.28%)
Previous Close $50.02    52 Week High $45.58 
Open $50.29    52 Week Low $37.82 
Day High $50.70    P/E N/A 
Day Low $49.97    EPS $0.00 
Volume 422,755       

Pfizer Inc. (NYSE: PFE) Delayed: 30.26 +0.41 (1.37%)
Previous Close $29.85    52 Week High $37.39 
Open $30.05    52 Week Low $28.25 
Day High $30.29    P/E 18.34 
Day Low $29.88    EPS $1.65 
Volume 3,900,012